Vital Chemtech Limited has informed the Exchange regarding Appointment of Mr. Ajay Kumar Agrawal as Non- Executive Independent Director of the company w.e.f. March 29, 2025.
VITAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vital Chemtech Limited held its 4th Annual General Meeting on Saturday, September 27, 2025, via video conferencing, and all 10 resolutions were passed with overwhelming shareholder support. Key resolutions included the adoption of audited standalone and consolidated financial statements for FY ended March 31, 2025, re-appointment of Mrs. Sangeeta Vipul Bhatt (who retires by rotation), ratification of cost auditor remuneration, and the appointment of two new Independent Directors: Mr. Ajay Kumar Agrawal and Mr. Vivek Dinesh Nathwani. Shareholders also approved a change in designation of Mrs. Sangeeta Vipul Bhatt from Whole Time Director to Non-Executive Director, material related party transactions with Vital Chemicals and Vital Synthesis Limited for FY 2025-26, and the Vital Employee Stock Option Scheme 2025 including its extension to group company employees. Of 23,951,100 total shares, 17,871,900 shares (74.62%) were polled, and promoters (holding ~73.4%) voted 100% in favor across all resolutions. Only the ESOP resolutions saw minor dissent, with 1,200 votes (0.42%) against.
Passage of all resolutions is largely procedural and positive for the company, confirming shareholder backing for new independent directors and the ESOP scheme. The ESOP 2025 approval may lead to future equity dilution for existing shareholders, while the re-designation of promoter family member Mrs. Sangeeta Vipul Bhatt from Whole Time to Non-Executive Director signals a governance shift. The very high promoter voting dominance (100% in favor) means retail shareholders had minimal influence on outcomes.